Skip to content
SupplementMagazine

Everyday Benefits

Berberine Patches: Each Holds 7-9 mg, the Trials Used 1,500 a Day

By Emrah Sümer, Founder & Managing Editor
October 23, 2026
A round yellow disc, scattered yellow powder and a white plate holding a pool of yellow liquid on pale linen
A round yellow disc, scattered yellow powder and a white plate holding a pool of yellow liquid on pale linen

Key takeaways

  • Kind Patches lists 8.75 mg of berberine extract per patch; PatchAid lists 7 mg. The 2008 diabetes pilot used 1,500 mg a day by mouth.
  • We found no human study, as of 23 October 2026, measuring berberine in blood or any metabolic outcome from a berberine patch.
  • In rat skin, only trace amounts of berberine permeated, which the authors put down to its low oil-water partition coefficient.
  • The only study showing systemic berberine through skin used rats, an engineered formulation and authors employed by the company holding a patent on it.
  • Federal law defines a dietary supplement as intended for ingestion. A 2026 review of 24 transdermal 'GLP-1' supplement patches, berberine the most listed ingredient, found no certificates of analysis posted.

Berberine patches are sold on a simple promise: the capsule is hard on the stomach and poorly absorbed, so stick the berberine on your skin instead. It sounds like a fix for a known problem. It is worth checking each half of it, starting with what is actually in the patch.

What is in the patch

Two product pages, read on 23 October 2026, put a number on it.

Kind Patches lists “Berberine Extract (8.75mg)” per patch, alongside 2.75 mg of cinnamon extract and 3.5 mg of L-glutamine. The product is titled “GLP-1 Friendly”.

PatchAid lists an “Advanced Berberine Herbal Complex (20 mg)”, of which berberine extract is 7 mg, with pomegranate, cinnamon and gymnema making up the rest. You wear one for up to eight hours a day.

The trial most often cited for berberine is a 2008 pilot in newly diagnosed type 2 diabetes. It gave berberine at “0.5 g 3 times a day” for three months. That is 1,500 mg a day.

ProductBerberine extract per patchPatches to equal one trial day (1,500 mg)
Kind Patches8.75 mgabout 171
PatchAid7 mgabout 214

That table is our arithmetic, and it is not a fair comparison on its own. Oral berberine reaches the blood very poorly, so most of those 1,500 milligrams never circulate either. If a patch delivered all 8.75 mg into the body, the gap would shrink a great deal. Whether it delivers any is the real question.

Can berberine get through skin?

Size is not the problem. Berberine weighs 336 daltons, according to PubChem. Dermatologists Bos and Meinardi argued in 2000 that “the molecular weight (MW) of a compound must be under 500 Dalton to allow skin absorption.” Berberine passes that test.

Charge is the problem. PubChem lists berberine with a formal charge of +1. It is a quaternary ammonium ion, which means the positive charge is permanent, and the outer layer of skin is an oily barrier that charged molecules cross badly.

The experiments match that. In 1999, a team in Taiwan put berberine in a chitosan gel and measured how much crossed rat skin. Their finding: “only trace amounts of berberine permeated through the rat skin due to its low oil-water partition coefficient.” They then had to add surfactants to push more of it in.

A 2018 pharmaceutics group in Egypt put it plainly: berberine’s “high aqueous solubility and limited permeability hinder its clinical topical application.” Their solution was to bind it to oleate, a fatty molecule, to make it more lipid-soluble, and they tested that in rats.

That pattern runs through the research. Laboratories getting berberine into skin use ion pairing, nanovesicles, micelles or microneedles. They are mostly trying to treat skin conditions such as psoriasis and wounds, where berberine only needs to reach the skin. None of that is the same as a stick-on patch carrying berberine into your bloodstream.

The one study that got berberine into the blood through skin

There is one study showing systemic berberine after skin application, and it needs its context first.

In 2018, researchers gave rats berberine and dihydroberberine in transdermal formulations they had developed, and compared them with oral berberine. Blood levels ranked transdermal dihydroberberine first, transdermal berberine second and oral berberine a distant third.

The authors “are/were employees of Delivra Corp. which has a pending patent on the formulation of topical berberine and dihydroberberine.” It was a rat study. And it tested an engineered formulation, not the adhesive patches sold online. It shows that skin delivery of berberine can be engineered in rats. It does not show that an adhesive patch from a shop does it in people.

No human study

We searched PubMed on 23 October 2026 for “berberine transdermal” (48 results), “berberine patch” (78) and “berberine skin permeation” (25). The results were laboratory formulations, animal studies of skin disease and the rat study above.

We found no study that applied a berberine patch to people and measured berberine in their blood, their blood sugar, their cholesterol or their weight.

Kind Patches answers “Is there evidence supporting the effectiveness of Berberine Patches?” with “Yes”. The evidence it lists is for the ingredients, and the first berberine link goes to a blog post on Medium. Studies of berberine swallowed at 1,500 mg a day are not evidence for 8.75 mg on the skin.

Skipping the gut may skip the point

The patch pitch treats poor oral absorption as a defect to route around. The trial evidence suggests it may be part of how berberine works.

In rats, “approximately half of berberine ran intact through the gastrointestinal tract”, and berberine concentrated in the liver at roughly 70 times plasma levels. The human trials measured HbA1c and lipids, not blood berberine, and those outcomes moved even though blood levels are barely detectable. The explanation consistent with that is a drug acting in the gut and liver. We set out that argument in our piece on berberine potency and absorption.

If that is right, a patch is not a better delivery route to the same effect. It bypasses the organs the effect may depend on.

Federal law defines a dietary supplement as a product “intended for ingestion”. A patch is not ingested.

In 2026, three pharmacy researchers at the University of Connecticut reviewed transdermal products sold as natural GLP-1 supplements in the Annals of Pharmacotherapy. They identified 24 patches and one gel. Berberine was among the most listed ingredients, and products averaged seven ingredients each. Their conclusion: “The Dietary Supplement Health and Education Act specifies dietary supplement products must be swallowed, so all these products are illegal.” They also found that “No certificates of analysis were posted” and that many products lacked the required FDA disclaimer.

That is the authors’ reading of the law. We have not seen the FDA act against a berberine patch brand.

The confusion shows up on the listings themselves. One berberine patch on Amazon, from Thrivia, carries “For external use only” under its safety information and a dietary supplement disclaimer under its legal section. Amazon’s returns note calls it “non-returnable due to potential safety risk as an ingestible product”. It is sold as a supplement, labelled as something not to eat, and treated by the retailer as something you swallow.

Moringa berberine microneedle patches

Some of the most searched products are “moringa berberine” patches described as microneedle patches. These are a different design: tiny projections pierce the outer skin layer, which is the barrier the adhesive patches cannot cross.

There is laboratory support for the principle. A 2024 study used chitosan microneedles loaded with berberine and imaged skin tissue, concluding that berberine “could permeate to both epidermis and dermis regions of the skin.” That study measured where berberine sat in skin. It did not measure blood levels, blood sugar or weight. We found no human trial of a berberine microneedle patch for any metabolic outcome.

What this means if you want berberine

  • The evidence for berberine is for berberine taken by mouth, in the trials at 500 mg three times a day, split across meals.
  • A patch has not been shown to deliver berberine into the body in people, at any dose, and the doses on the two labels we read are a fraction of a percent of the trial dose.
  • “GLP-1” on a patch is marketing. We found no study measuring GLP-1 from a berberine patch.
  • If you take diabetes medication, talk to your doctor before adding oral berberine, because that form does lower blood sugar. If you are relying on a patch instead of prescribed treatment, that is the risk worth taking seriously.

Frequently asked questions

Do berberine patches work?

There is no published evidence that they do, and that is a statement about absence of testing rather than a test that failed. Searching PubMed on 23 October 2026 for transdermal berberine and berberine patches returned laboratory and animal work on skin conditions such as psoriasis, wounds and eczema, plus one rat pharmacokinetic study. We found no study that put a berberine patch on people and measured berberine in their blood, their blood sugar, their weight or anything else. The patch brands we read cite studies of berberine taken by mouth, which is a different route, at a dose roughly 170 to 210 times higher per day.

How much berberine is in a berberine patch?

On the two product pages we read, very little. Kind Patches lists Berberine Extract at 8.75 mg per patch. PatchAid lists an Advanced Berberine Herbal Complex of 20 mg, of which berberine extract is 7 mg, alongside pomegranate, cinnamon and gymnema. Both are worn once a day for up to about eight hours. For comparison, the 2008 pilot trial in newly diagnosed type 2 diabetes used 0.5 g three times a day, which is 1,500 mg daily. Note that 'berberine extract' on a label is not necessarily pure berberine, so the actual berberine content could be lower still.

Can berberine be absorbed through the skin?

Its size is not the barrier. Berberine weighs about 336 daltons, under the 500 dalton threshold that dermatologists Bos and Meinardi proposed for skin penetration. Its charge is the barrier. Berberine is a quaternary ammonium ion with a permanent positive charge, and charged molecules cross the oily outer layer of skin poorly. A 1999 study testing berberine in a chitosan gel found that only trace amounts permeated rat skin in vitro, because of its low oil-water partition coefficient, and needed surfactants to push more through. A 2018 pharmaceutics paper described berberine's high water solubility and limited permeability as what hinders its topical use.

Isn't a patch better because it skips poor oral absorption?

That is the marketing argument, and it has a real starting point: oral berberine reaches the blood poorly. But two things undercut it. First, the skin is a worse barrier for berberine than the gut, on the evidence above. Second, the oral trials may have worked because of where berberine goes, not despite it. Rat studies found about half an oral dose stays in the gut and berberine concentrates in the liver at roughly 70 times plasma levels. A patch that skips the gut and liver skips the route the clinical results were produced through. The only study showing better blood levels through skin was a rat study of an engineered gel, run by employees of the company holding the patent.

Are berberine patches legal?

As dietary supplements, a 2026 review argues they are not. The federal definition at 21 U.S.C. 321(ff) says a dietary supplement is a product intended for ingestion. Writing in the Annals of Pharmacotherapy, three University of Connecticut pharmacy researchers identified 24 transdermal patch supplements and one gel sold as natural GLP-1 products, with berberine among the most listed ingredients, and concluded that all of them were illegal for that reason. They also found no certificates of analysis posted and many products missing the required FDA disclaimer. We have not seen FDA enforcement action against a berberine patch brand; that is the authors' legal reading, not a ruling.

What about moringa berberine microneedle patches?

Those are a different design. Microneedle patches carry tiny projections that pierce the outer skin layer, which is the barrier a plain adhesive patch cannot get past. Laboratory work has shown that chitosan microneedles can carry berberine into the epidermis and dermis, but that research measured where berberine sat in skin tissue, not blood levels or weight in people. We found no human trial of a berberine microneedle patch for weight or blood sugar either.

Are berberine patches safe?

There is little to go on. No human safety data for a berberine patch turned up in our search. Kind Patches states 'No side effects', which no study we found supports or tests. Low doses and poor skin penetration make serious harm unlikely, and skin irritation from the adhesive is the most plausible problem. If you take diabetes medication, the bigger risk is the opposite one: relying on a patch that has not been shown to do anything instead of a treatment that has.

Sources

Every claim above is drawn from these primary sources. Last checked July 2026.

  1. 1.Tsai CJ, Hsu LR, Fang JY, Lin HH. Chitosan hydrogel as a base for transdermal delivery of berberine and its evaluation in rat skin. Biological and Pharmaceutical Bulletin. 1999;22(4):397-401. PMID 10328561. Quoted: 'In in vitro skin perfusion studies, only trace amounts of berberine permeated through the rat skin due to its low oil-water partition coefficient.' Surfactants were then tested as penetration enhancers. Checked 23 October 2026
  2. 2.Torky AS, Freag MS, Nasra MMA, Abdallah OY. Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach. International Journal of Pharmaceutics. 2018;549(1-2):76-86. PMID 30053489. Quoted: 'Brb's high aqueous solubility and limited permeability hinder its clinical topical application.' Rat skin, ex vivo and in vivo. Checked 23 October 2026
  3. 3.Buchanan B, Meng Q, Poulin MM, et al. Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine. PLoS One. 2018;13(3):e0194979. PMID 29579096. Sprague-Dawley rats; transdermal formulations developed by the authors ranked above oral berberine for blood levels. Competing interests, quoted: 'The authors are/were employees of Delivra Corp. which has a pending patent on the formulation of topical berberine and dihydroberberine.' Checked 23 October 2026
  4. 4.White CM, Tai Z, Nuzi K. Transdermal 'Natural GLP-1' Dietary Supplements Violate Law and Place Patients at Risk. Annals of Pharmacotherapy. 2026;60(8):813-816. PMID 41480958. Quoted: 'The Dietary Supplement Health and Education Act specifies dietary supplement products must be swallowed, so all these products are illegal. We identified 24 transdermal patch dietary supplement products and 1 transdermal gel product with an average of 7 ± 4 natural ingredients (berberine, glutamine/glutamate, cinnamon, and pomegranate most listed). No certificates of analysis were posted, many products lacked the Food and Drug Administration disclaimer.' Authors declared no conflicts. Checked 23 October 2026
  5. 5.21 U.S.C. 321(ff), definition of dietary supplement. Quoted: a dietary supplement 'means a product that (A)(i) is intended for ingestion in a form described in section 350(c)(1)(B)(i) of this title'. Checked 23 October 2026
  6. 6.Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Experimental Dermatology. 2000;9(3):165-169. PMID 10839713. Quoted: 'We argue that the molecular weight (MW) of a compound must be under 500 Dalton to allow skin absorption.' Checked 23 October 2026
  7. 7.PubChem, berberine (CID 2353): molecular formula C20H18NO4+, molecular weight 336.4 g/mol, formal charge +1. Checked 23 October 2026
  8. 8.Cui X, Geng H, Guo H, et al. Visualizing the transdermal delivery of berberine loaded within chitosan microneedles using mass spectrometry imaging. Analytical and Bioanalytical Chemistry. 2024;416(29):6869-6877. PMID 39400576. Quoted: 'BR was effectively delivered and could permeate to both epidermis and dermis regions of the skin.' Skin tissue imaging; no blood levels or human outcomes. Checked 23 October 2026
  9. 9.Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712-717. PMID 18442638. Quoted: '36 adults with newly diagnosed type 2 diabetes mellitus were randomly assigned to treatment with berberine or metformin (0.5 g 3 times a day) in a 3-month trial.' Checked 23 October 2026
  10. 10.Liu YT, Hao HP, Xie HG, et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats. Drug Metabolism and Disposition. 2010;38(10):1779-1784. PMID 20634337. Quoted: 'approximately half of berberine ran intact through the gastrointestinal tract' and 'a 70-fold increase in the ratio of the area under the concentration-time curve value for berberine (liver versus plasma).' Checked 23 October 2026
  11. 11.Kind Patches, Berberine Patches (GLP-1 Friendly), product page. Lists 'Berberine Extract (8.75mg)', 'Cinnamon Extract (2.75mg)', 'L-Glutamine (3.5mg)'; states 'No side effects'. Its evidence section links berberine 'Study 1' to a Medium blog post. Checked 23 October 2026
  12. 12.PatchAid, Berberine Patch, product listing at Netrition. Lists 'Advanced Berberine Herbal Complex (20 mg): Berberine Extract (7 mg), Pomegranate Extract (5 mg), Cinnamon Extract (4 mg), and Gymnema Sylvestre Extract (4 mg)'; 'Wear one patch for up to 8 hours per day.' Checked 23 October 2026
  13. 13.Thrivia Berberine Patches, Amazon listing B0GK389LBX. Safety information: 'For external use only.' Legal disclaimer: 'Statements regarding dietary supplements have not been evaluated by the FDA.' Returns: 'non-returnable due to potential safety risk as an ingestible product'. Checked 23 October 2026